Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05936710
NA

Improved Hemodynamic Tolerance of Intermittent Hemodialysis Sessions in Intensive Care Unite Using Citrate- vs Acetate-based Dialysate

Sponsor: Centre Hospitalier de Bethune

View on ClinicalTrials.gov

Summary

During intermittent hemodialysis (IHD), the occurrence of intradialytic hemodynamic instability (IHI) is frequent in ICU and impacted morbidity and mortality. Bicarbonate dialysate buffer improves hemodynamic tolerance compared to acetate dialysate buffer. However, bicarbonate dialysate buffer still contains a lower concentration of acetate, which could contribute to hemodynamic instability. Recently, citrate-based dialysate in bicarbonate hemodialysis instead of acetate have been proposed. They have the appropriate authorizations for routine use. The aim of this study is to compare acetate- vs citrate-based dialysate in terms of hemodynamic tolerance and effectiveness.

Official title: Improved Hemodynamic Tolerance of Intermittent Hemodialysis Sessions in Intensive Care Unite (ICU) Using Citrate- vs Acetate-based Dialysate

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

48

Start Date

2023-12-07

Completion Date

2027-07

Last Updated

2026-01-06

Healthy Volunteers

No

Interventions

DEVICE

ACETATE based dialysate

Intermittent hemodialysis with an acetate based dialysate.

DEVICE

CITRATE based dialysate

Intermittent hemodialysis with an citrate based dialysate.

Locations (4)

Centre Hospitalier Béthune

Béthune, France

CHU

Caen, France

Centre Hospitalier Universitaire de Dijon

Dijon, France

CHRU Nancy

Nancy, France